Study identifies potential epigenetic biomarker for preeclampsia

Analysis of cheek swabs taken from pregnant women revealed a potential epigenetic biomarker for preeclampsia, a potentially life-threatening condition that often leads to preterm births.

New “fusion sites” enable faster and more targeted drug development

Many important medicines, such as antibiotics and anticancer drugs, are derived from natural products from Bacteria.

March 22, 2024

MarketingRx roundup: Pfizer switches up advertising duties; Novo Nordisk’s Ozempic gets spoofed on SNL

Pfizer moves creative advertising work to Publicis: Less than a year after Pfizer consolidated ad agency relationships under a dual system of responsibilities, it’s changing tacks

April 3, 2024

Intellia plays down concerns about accidental germline transmission in CRISPR trial

Earlier this month, Intellia Therapeutics announced it was scrapping plans to include U.S.-based sites in one of its mid-stage CRISPR trials after the Food and

August 21, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.